Skip to main content
Erschienen in: Annals of Surgical Oncology 1/2018

01.11.2017 | Gastrointestinal Oncology

Short-Term Outcomes Following Minimally Invasive and Open Esophagectomy: A Population-Based Study from Finland and Sweden

verfasst von: Joonas H. Kauppila, MD, PhD, Olli Helminen, MD, PhD, Ville Kytö, MD, PhD, Jarmo Gunn, MD, PhD, Jesper Lagergren, MD, PhD, Eero Sihvo, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Population-based studies comparing minimally invasive esophagectomy (MIE) and open esophagectomy (OE) relative to 90-day postoperative mortality are needed.

Objective

The aim of this study was to compare short-term outcomes following these two techniques for esophageal cancer.

Methods

Patients undergoing MIE (n = 217) or OE (n = 1397) for esophageal cancer between 2007 and 2014 were identified from nationwide complete registries in Finland and Sweden. The primary outcome was 90-day mortality, and secondary outcomes were 30-day mortality, length of hospital stay, and 30- and 90-day readmission rate. Results were adjusted for age, sex, comorbidity, tumor histology, surgery year, and country.

Results

Ninety-day mortality rates were 4.1% (n = 9 of 217) for MIE and 6.8% (n = 95 of 1397) for OE; 90-day mortality was halved after MIE [adjusted hazard ratio (HR) 0.49, 95% confidence interval (CI) 0.24–0.99]. There was no difference in 30-day mortality (adjusted HR 0.87, 95% CI 0.29–2.66). Median hospital stay was 15 days for MIE and 16 days for OE (adjusted β −0.17, standard error 0.08, p = 0.030). The 30-day readmission rates were 8.9% after MIE and 12.0% after OE (adjusted HR 0.57, 95% CI 0.34–0.94), while the 90-day readmission rates were 28.8% and 33.6%, respectively, without a statistically significant difference (adjusted HR 0.82, 95% CI 0.61–1.10).

Conclusions

This population-based study from Finland and Sweden revealed lower 90-day mortality, shorter hospital stay, and lower 30-day readmission rates after MIE compared with OE for esophageal cancer. These findings support the use of minimally invasive approaches.
Literatur
1.
Zurück zum Zitat Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease Study. JAMA Oncol. 2017;3:524–48. Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease Study. JAMA Oncol. 2017;3:524–48.
2.
Zurück zum Zitat Lordick F, Mariette C, Haustermans K, et al. Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27:v50–7.CrossRefPubMed Lordick F, Mariette C, Haustermans K, et al. Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27:v50–7.CrossRefPubMed
3.
Zurück zum Zitat Lazzarino AI, Nagpal K, Bottle A, et al. Open versus minimally invasive esophagectomy: trends of utilization and associated outcomes in England. Ann Surg. 2010;252:292–8.CrossRefPubMed Lazzarino AI, Nagpal K, Bottle A, et al. Open versus minimally invasive esophagectomy: trends of utilization and associated outcomes in England. Ann Surg. 2010;252:292–8.CrossRefPubMed
4.
Zurück zum Zitat Luketich JD, Alvelo-Rivera M, Buenaventura PO, et al. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg. 2003;238:486–94; discussion 494–5. Luketich JD, Alvelo-Rivera M, Buenaventura PO, et al. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg. 2003;238:486–94; discussion 494–5.
5.
Zurück zum Zitat Pennathur A, Luketich JD. Minimally invasive esophagectomy: short-term outcomes appear comparable to open esophagectomy. Ann Surg. 2012;255:206–7.CrossRefPubMed Pennathur A, Luketich JD. Minimally invasive esophagectomy: short-term outcomes appear comparable to open esophagectomy. Ann Surg. 2012;255:206–7.CrossRefPubMed
6.
Zurück zum Zitat Luketich JD, Pennathur A, Awais O, et al. Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg. 2012;256:95–103.CrossRefPubMedPubMedCentral Luketich JD, Pennathur A, Awais O, et al. Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg. 2012;256:95–103.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Palazzo F, Rosato EL, Chaudhary A, et al. Minimally invasive esophagectomy provides significant survival advantage compared with open or hybrid esophagectomy for patients with cancers of the esophagus and gastroesophageal junction. J Am Coll Surg. 2015;220:672–9.CrossRefPubMed Palazzo F, Rosato EL, Chaudhary A, et al. Minimally invasive esophagectomy provides significant survival advantage compared with open or hybrid esophagectomy for patients with cancers of the esophagus and gastroesophageal junction. J Am Coll Surg. 2015;220:672–9.CrossRefPubMed
8.
Zurück zum Zitat Sihag S, Wright CD, Wain JC, et al. Comparison of perioperative outcomes following open versus minimally invasive Ivor Lewis oesophagectomy at a single, high-volume centre. Eur J Cardiothorac Surg. 2012;42:430-437.CrossRefPubMed Sihag S, Wright CD, Wain JC, et al. Comparison of perioperative outcomes following open versus minimally invasive Ivor Lewis oesophagectomy at a single, high-volume centre. Eur J Cardiothorac Surg. 2012;42:430-437.CrossRefPubMed
9.
Zurück zum Zitat Biere SS, van Berge Henegouwen MI, Maas KW, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet. 2012;379:1887–92.CrossRefPubMed Biere SS, van Berge Henegouwen MI, Maas KW, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet. 2012;379:1887–92.CrossRefPubMed
10.
Zurück zum Zitat Straatman J, van der Wielen N, Cuesta MA, et al. Minimally invasive versus open esophageal resection: three-year Follow-up of the previously reported randomized controlled trial: the TIME trial. Ann Surg. 2017;266(2):232–6.CrossRefPubMed Straatman J, van der Wielen N, Cuesta MA, et al. Minimally invasive versus open esophageal resection: three-year Follow-up of the previously reported randomized controlled trial: the TIME trial. Ann Surg. 2017;266(2):232–6.CrossRefPubMed
11.
Zurück zum Zitat Mamidanna R, Bottle A, Aylin P, et al. Short-term outcomes following open versus minimally invasive esophagectomy for cancer in England: a population-based national study. Ann Surg. 2012;255:197–203.CrossRefPubMed Mamidanna R, Bottle A, Aylin P, et al. Short-term outcomes following open versus minimally invasive esophagectomy for cancer in England: a population-based national study. Ann Surg. 2012;255:197–203.CrossRefPubMed
12.
Zurück zum Zitat Takeuchi H, Miyata H, Ozawa S, et al. Comparison of short-term outcomes between open and minimally invasive esophagectomy for esophageal cancer using a nationwide database in Japan. Ann Surg Oncol. 2017;24(7):1821–7.CrossRefPubMed Takeuchi H, Miyata H, Ozawa S, et al. Comparison of short-term outcomes between open and minimally invasive esophagectomy for esophageal cancer using a nationwide database in Japan. Ann Surg Oncol. 2017;24(7):1821–7.CrossRefPubMed
13.
Zurück zum Zitat Sihag S, Kosinski AS, Gaissert HA, et al. Minimally invasive versus open esophagectomy for esophageal cancer: a comparison of early surgical outcomes from The Society of Thoracic Surgeons National Database. Ann Thorac Surg. 2016;101:1281–8; discussion 1288–9. Sihag S, Kosinski AS, Gaissert HA, et al. Minimally invasive versus open esophagectomy for esophageal cancer: a comparison of early surgical outcomes from The Society of Thoracic Surgeons National Database. Ann Thorac Surg. 2016;101:1281–8; discussion 1288–9.
14.
Zurück zum Zitat In H, Palis BE, Merkow RP, et al. Doubling of 30-day mortality by 90 days after esophagectomy: a critical measure of outcomes for quality improvement. Ann Surg. 2016;263:286–91.CrossRefPubMed In H, Palis BE, Merkow RP, et al. Doubling of 30-day mortality by 90 days after esophagectomy: a critical measure of outcomes for quality improvement. Ann Surg. 2016;263:286–91.CrossRefPubMed
15.
Zurück zum Zitat Rutegard M, Lagergren P, Johar A, et al. Time shift in early postoperative mortality after oesophagectomy for cancer. Ann Surg Oncol. 2015;22:3144–9.CrossRefPubMed Rutegard M, Lagergren P, Johar A, et al. Time shift in early postoperative mortality after oesophagectomy for cancer. Ann Surg Oncol. 2015;22:3144–9.CrossRefPubMed
16.
Zurück zum Zitat Talsma AK, Lingsma HF, Steyerberg EW, et al. The 30-day versus in-hospital and 90-day mortality after esophagectomy as indicators for quality of care. Ann Surg. 2014;260:267–73.CrossRefPubMed Talsma AK, Lingsma HF, Steyerberg EW, et al. The 30-day versus in-hospital and 90-day mortality after esophagectomy as indicators for quality of care. Ann Surg. 2014;260:267–73.CrossRefPubMed
17.
Zurück zum Zitat Messager M, Pasquer A, Duhamel A, et al. Laparoscopic gastric mobilization reduces postoperative mortality after esophageal cancer surgery: a French Nationwide Study. Ann Surg. 2015;262:817–22; discussion 822–3. Messager M, Pasquer A, Duhamel A, et al. Laparoscopic gastric mobilization reduces postoperative mortality after esophageal cancer surgery: a French Nationwide Study. Ann Surg. 2015;262:817–22; discussion 822–3.
18.
Zurück zum Zitat Korhonen P, Malila N, Pukkala E, et al. The Finnish Cancer Registry as follow-up source of a large trial cohort: accuracy and delay. Acta Oncol. 2002;41:381–8.CrossRefPubMed Korhonen P, Malila N, Pukkala E, et al. The Finnish Cancer Registry as follow-up source of a large trial cohort: accuracy and delay. Acta Oncol. 2002;41:381–8.CrossRefPubMed
19.
Zurück zum Zitat Lindblad M, Ye W, Lindgren A, et al. Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates. Ann Surg. 2006;243:479–85.CrossRefPubMedPubMedCentral Lindblad M, Ye W, Lindgren A, et al. Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates. Ann Surg. 2006;243:479–85.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Sund R. Quality of the Finnish Hospital Discharge Register: a systematic review. Scand J Public Health. 2012;40:505–15.CrossRefPubMed Sund R. Quality of the Finnish Hospital Discharge Register: a systematic review. Scand J Public Health. 2012;40:505–15.CrossRefPubMed
21.
Zurück zum Zitat Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.CrossRefPubMedPubMedCentral Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130–39.CrossRefPubMed Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130–39.CrossRefPubMed
23.
Zurück zum Zitat Nilsson M, Kamiya S, Lindblad M, et al. Implementation of minimally invasive esophagectomy in a tertiary referral center for esophageal cancer. J Thorac Dis. 2017;9:S817–25.CrossRefPubMedPubMedCentral Nilsson M, Kamiya S, Lindblad M, et al. Implementation of minimally invasive esophagectomy in a tertiary referral center for esophageal cancer. J Thorac Dis. 2017;9:S817–25.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Kauppi J, Rasanen J, Sihvo E, et al. Open versus minimally invasive esophagectomy: clinical outcomes for locally advanced esophageal adenocarcinoma. Surg Endosc. 2015;29:2614–9.CrossRefPubMed Kauppi J, Rasanen J, Sihvo E, et al. Open versus minimally invasive esophagectomy: clinical outcomes for locally advanced esophageal adenocarcinoma. Surg Endosc. 2015;29:2614–9.CrossRefPubMed
25.
Zurück zum Zitat Rouvelas I, Zeng W, Lindblad M, et al. Survival after surgery for oesophageal cancer: a population-based study. Lancet Oncol. 2005;6:864–70.CrossRefPubMed Rouvelas I, Zeng W, Lindblad M, et al. Survival after surgery for oesophageal cancer: a population-based study. Lancet Oncol. 2005;6:864–70.CrossRefPubMed
26.
Zurück zum Zitat Kassin MT, Owen RM, Perez SD, et al. Risk factors for 30-day hospital readmission among general surgery patients. J Am Coll Surg. 2012;215:322–30.CrossRefPubMedPubMedCentral Kassin MT, Owen RM, Perez SD, et al. Risk factors for 30-day hospital readmission among general surgery patients. J Am Coll Surg. 2012;215:322–30.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Brusselaers N, Mattsson F, Lagergren J. Hospital and surgeon volume in relation to long-term survival after oesophagectomy: systematic review and meta-analysis. Gut. 2014;63:1393–400.CrossRefPubMed Brusselaers N, Mattsson F, Lagergren J. Hospital and surgeon volume in relation to long-term survival after oesophagectomy: systematic review and meta-analysis. Gut. 2014;63:1393–400.CrossRefPubMed
28.
Zurück zum Zitat Zhou C, Zhang L, Wang H, et al. Superiority of minimally invasive oesophagectomy in reducing in-hospital mortality of patients with resectable oesophageal cancer: a meta-analysis. PLoS ONE 2015;10:e0132889.CrossRefPubMedPubMedCentral Zhou C, Zhang L, Wang H, et al. Superiority of minimally invasive oesophagectomy in reducing in-hospital mortality of patients with resectable oesophageal cancer: a meta-analysis. PLoS ONE 2015;10:e0132889.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Yerokun BA, Sun Z, Jeffrey Yang CF, et al. Minimally invasive versus open esophagectomy for esophageal cancer: a population-Based analysis. Ann Thorac Surg. 2016;102:416–23.CrossRefPubMedPubMedCentral Yerokun BA, Sun Z, Jeffrey Yang CF, et al. Minimally invasive versus open esophagectomy for esophageal cancer: a population-Based analysis. Ann Thorac Surg. 2016;102:416–23.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Parameswaran R, Blazeby JM, Hughes R, et al. Health-related quality of life after minimally invasive oesophagectomy. Br J Surg. 2010;97:525–31.CrossRefPubMed Parameswaran R, Blazeby JM, Hughes R, et al. Health-related quality of life after minimally invasive oesophagectomy. Br J Surg. 2010;97:525–31.CrossRefPubMed
31.
Zurück zum Zitat Maas KW, Cuesta MA, van Berge Henegouwen MI, et al. Quality of life and late complications after minimally invasive compared to open esophagectomy: results of a randomized trial. World J Surg. 2015;39:1986–93.CrossRefPubMedPubMedCentral Maas KW, Cuesta MA, van Berge Henegouwen MI, et al. Quality of life and late complications after minimally invasive compared to open esophagectomy: results of a randomized trial. World J Surg. 2015;39:1986–93.CrossRefPubMedPubMedCentral
Metadaten
Titel
Short-Term Outcomes Following Minimally Invasive and Open Esophagectomy: A Population-Based Study from Finland and Sweden
verfasst von
Joonas H. Kauppila, MD, PhD
Olli Helminen, MD, PhD
Ville Kytö, MD, PhD
Jarmo Gunn, MD, PhD
Jesper Lagergren, MD, PhD
Eero Sihvo, MD, PhD
Publikationsdatum
01.11.2017
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 1/2018
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-017-6212-9

Weitere Artikel der Ausgabe 1/2018

Annals of Surgical Oncology 1/2018 Zur Ausgabe

Health Services Research and Global Oncology

What Is a Surgical Oncologist?

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.